GNRH1 and Dyspareunia: In particular, patients taking tamoxifen plus GnRH agonists more often reported hot flushes, vaginal dryness, arthralgia and dyspareunia, while patients taking AIs plus GnRH agonists more often reported hot flushes, vaginal dryness, dyspareunia, mood changes, decreased libido and anxiety (Figure 2).